Emphasis
The program includes the delivery of healthcare that is safe, effective, timely, patient-centered, efficient, and available in centralized and decentralized locations. The emphasis is on developing technologies driven by clinical needs. Examples of technology development areas in this program include but are not limited to disposable lateral flow assays, nucleic acid testing platforms, glucose monitoring devices, etc.
Program priorities
- Rapid: ideal diagnostic test time to identify species and determine drug susceptibility profiles, process the clinical sample (if appropriate), and detection and delivery of the final test result during a single interaction
- Sensitive: sensitivity should be equivalent to or exceed current standards for proposed targets from the same sample type
- Specific: specificity should be equivalent to or exceed current standards for proposed targets from the same sample type
- Easy-to-use: integrated, closed sample-to-answer system with automated data analyses and/or result presentation and with minimal operator training and expertise required
- Cost-effective: projected production and operating costs should be consistent or an improvement on commonly used platforms
Featured programs and resources
Point of Care Technology Research Network
NIBIB created the Point-of-Care Technologies Research Network (POCTRN) to drive the development of appropriate point-of-care diagnostic technologies through collaborative efforts that merge scientific and technological capabilities with clinical need. Details about this program are on the POCTRN page.
Find current solicitations for POCTRN centers.
Join the NIBIB Point of Care Technologies listserv: the e-newsletter serves as an information outlet to the Point of Care Technology community on current activities and initiatives involving point of care technology research supported by the National Institutes of Health.
Related News
Brain cancer is the second most common cancer in children after leukemia, and it is also the deadliest, due to the fact that brain tumors are diverse, resistant to treatments and often hard to access surgically. A collaborative team of researchers at several institutions have developed a new way to profile brain cancers in children, paving the way for improved diagnostics and treatments. Source: UTSA Today
The National Institutes of Health (NIH) has selected four finalists with innovative, non-invasive technologies that seek to improve diagnosis of endometriosis.
NIH has awarded more than $4 million in funds and support services to three diagnostic technology developers as part of RADx ® Tech’s Advanced Platforms for HIV Viral Load Monitoring program.
A tiny, four-fingered “hand” folded from a single piece of DNA can pick up the virus that causes COVID-19 for highly sensitive rapid detection and can even block viral particles from entering cells to infect them, University of Illinois Urbana-Champaign researchers report. Source: University of Illinois Urbana-Champaign News Bureau
The National Institutes of Health and the higher education non-profit VentureWell have selected 11 winners and five honorable mentions in the Design by Biomedical Undergraduate Teams (DEBUT) Challenge, who are set to receive prizes totaling $160,000.